BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11108514)

  • 1. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report.
    Serdaroğlu A; Simşek F; Gücüyener K; Oğuz A; Karadeniz C; Balibey M
    J Child Neurol; 2000 Nov; 15(11):765-7. PubMed ID: 11108514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moya-Moya syndrome after cranial radiation for optic glioma with NF1. Case report and literature review of syndromic cases.
    Brandicourt P; Bonnet L; Béjot Y; Drouet C; Moulin T; Thines L
    Neurochirurgie; 2018 Mar; 64(1):63-67. PubMed ID: 29475609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-Onset Hemorrhagic Quasi-Moyamoya Disease with Unilateral Steno-occlusive Lesion in a Patient with Neurofibromatosis Type 1.
    Hori YS; Ebisudani Y; Aoi M; Fukuhara T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1423-1424. PubMed ID: 29305273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome as a complication of radiation therapy. Case report.
    Servo A; Puranen M
    J Neurosurg; 1978 Jun; 48(6):1026-9. PubMed ID: 660236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood moyamoya syndrome. Postradiation pathogenesis.
    Rajakulasingam K; Cerullo LJ; Raimondi AJ
    Childs Brain; 1979; 5(5):467-75. PubMed ID: 477462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moyamoya phenomenon after radiation for optic glioma.
    Kestle JR; Hoffman HJ; Mock AR
    J Neurosurg; 1993 Jul; 79(1):32-5. PubMed ID: 8315466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibromatosis type 1 associated with moyamoya syndrome in children.
    Duat-Rodríguez A; Carceller Lechón F; López Pino MÁ; Rodríguez Fernández C; González-Gutiérrez-Solana L
    Pediatr Neurol; 2014 Jan; 50(1):96-8. PubMed ID: 24269170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced aneurysm and moyamoya vessels presenting with subarachnoid haemorrhage.
    Maruyama K; Mishima K; Saito N; Fujimaki T; Sasaki T; Kirino T
    Acta Neurochir (Wien); 2000; 142(2):139-43. PubMed ID: 10795887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1.
    Ullrich NJ; Zimmerman M; Smith E; Irons M; Marcus K; Kieran MW
    J Child Neurol; 2011 Feb; 26(2):228-30. PubMed ID: 20823033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
    Rosser TL; Vezina G; Packer RJ
    Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Ivy Sign" and Moyamoya Disease in a Child With Neurofibromatosis Type 1.
    Novara S; Singh S; Rashid S
    Pediatr Neurol; 2017 May; 70():80. PubMed ID: 28279525
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurofibromatosis type 1 associated with moyamoya syndrome. Case report and review of the literature.
    Budişteanu M; Burloiu CM; Papuc SM; Focşa IO; Riga D; Riga S; Arghir A
    Rom J Morphol Embryol; 2019; 60(2):713-716. PubMed ID: 31658349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Akin moyamoya disease in children].
    Inoue T; Matsushima T; Fujii K; Fukui M; Hasuo K; Matsuo H
    No Shinkei Geka; 1993 Jan; 21(1):59-65. PubMed ID: 8426689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moyamoya syndrome associated with severe iron deficiency anemia in a young child.
    Meena SS; Ramkumar TV; Sharma S; Aneja S; Kumar A
    Pediatr Hematol Oncol; 2012 May; 29(4):368-71. PubMed ID: 22568800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moyamoya syndrome related to neurofibromatosis of type 1: a case report.
    Delvoye F; Hervé D; Chabriat H; Mawet J
    Acta Neurol Belg; 2013 Dec; 113(4):539-41. PubMed ID: 24085541
    [No Abstract]   [Full Text] [Related]  

  • 16. Perfusion MRI abnormalities in the absence of diffusion changes in a case of moyamoya-like syndrome in neurofibromatosis type 1.
    El-Koussy M; Lövblad KO; Steinlin M; Kiefer C; Schroth G
    Neuroradiology; 2002 Nov; 44(11):938-41. PubMed ID: 12428131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya disease in a child with neurofibromatosis type-1.
    Kwong KL; Wong YC
    J Paediatr Child Health; 1999 Feb; 35(1):108-9. PubMed ID: 10234650
    [No Abstract]   [Full Text] [Related]  

  • 18. Poor wound healing after pial synangiosis in 2 children with moyamoya vasculopathy associated with neurofibromatosis type 1.
    Golomb MR; Smith JL
    J Child Neurol; 2014 Oct; 29(10):NP101-4. PubMed ID: 24141273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: Treatment-related late toxicity.
    Kortmann RD; Timmermann B; Taylor RE; Scarzello G; Plasswilm L; Paulsen F; Jeremic B; Gnekow AK; Dieckmann K; Kay S; Bamberg M
    Strahlenther Onkol; 2003 Sep; 179(9):585-97. PubMed ID: 14628124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.